|João Goulão||He is currently Portuguese Drugs and Alcohol National Coordinator and Director General of the Intervention on Addictive Behaviours and Dependencies General Directorate (SICAD), the body within the Health Ministry responsible for the policy coordination in this field. He was Chairman of the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) from 2009 to 2015 and he has a long experience in addictions field at international level.
A medical doctor by profession, Dr. Goulão has over 20 years’ experience regarding drug-related issues, working in this field since 1987 as general practitioner and since then all his professional life has been devoted to drugs and health. He was also a member of the Portuguese Committee which, in 1999, prepared the report on which the first Portuguese Drug Strategy was based and that included decriminalisation proposal.
|Matthew Hickman||Matt Hickman is Head of Population Health Science, Director of NIHR HPRU in Evaluation and Professor of Public Health and Epidemiology at University of Bristol|
|Greg Dore||Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.|
|Karine Lacombe||Pr Karine Lacombe professor of infectious and tropical diseases in Sorbonne-Université, St Antoine Hospital, Paris France. She has developed an expertise in the diagnosis, care and management of HIV and viral hepatitis in vulnerable populations. She has developed clinical research programmes in Europe, Sub-Saharan Africa and Asia on the issues of HIV-chronic hepatitis B and C, as well as co-morbidities associated with the use of antiretrovirals, She is part of the WHO Guidelines development groups for HIV, HBV and HCV, and acts as member of the European AIDS Clinical Society Guidelines group and the French committee for guidelines development in HIV and Hepatitis. She also serves in the UNAIDS Experts Panel and is a member of the EAG of the Medicine Patent Pool.|
|John Dillon||Prof John Dillon is Professor of Hepatology and Gastroenterology and a principle investigator, in the Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, based at Ninewells hospital, Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy hepatology service and a research group.|
|Shruti Mehta||Shruti Mehta is a Professor and the Deputy Chair of the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She received a Master’s in Public Health and a PhD in Epidemiology also from the Johns Hopkins Bloomberg School of Public Health. Her research focuses on hepatitis C virus (HCV) and HIV infection among people who inject drugs (PWID) in the US and in India with a particular interest and focus on identifying and overcoming barriers to access care and treatment for HIV and HCV.|
|Gabi Becker||Study of economics and science of economic education extra occupational. Working as managing director of Integrative Drogenhilfe e.V. Frankfurt since 2000 and deputy chief executive of the „Paritätische Wohlfahrtsverband Hessen“ since 2001 and deputy chairwoman of the supervisory Board of “Gemeinschaft Deutsche Altenhilfe” since 2002.
Focussing on the following topics:
• Addiction care - specially low threshold facilities
• Harm reduction
• Better Treatment for aging drug users
• Vocational Training
• Social Issues
• Women Issues
• Financial and Social Management
• Motivational Interviewing
|Ricardo Fuentes||Advisor for the Councilman of Education and Social Rights- Ricardo Robles- for LGBTI issues, HIV, Drugs and Sex Work in Lisbon City Council. Has been working since 2006 in harm reduction projects/drug consumption room and as a peer counsellor in HIV prevention and testing projects for men who have sex with men, in Spain and Portugal.|
|Julie Bruneau||Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal. She is recognized as a leader in addiction medicine in Canada, and was central in the development of the Opiate Agonist Treatment and Syringe Distribution Program networks in Quebec. Over the past 20 years, her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts among persons who inject drugs. She is currently Head of the Primary Care Department at the Centre Hospitalier de l’Université de Montréal.|
|Patrizia Carrieri||Patrizia Carrieri is the leader of the team on Hepatitis and Addiction at research at the French National Institute of Health and Medical Research in Marseille, France. She conducted extensive research on the role of buprenorphine on adherence to HIV treatment, the impact of methadone in primary care for HCV prevention and evaluated an innovative peer-to-peer educational intervention for people who inject drugs to prevent HCV. She is currently assessing the impact of behaviors on clinical outcomes in HIV-HCV cohort ANRS HEPAVIH and exploring barriers to care for people with alcool use disorders in France.|
|Annette Verster||Annette Verster works at the WHO/HIV department in Geneva as the technical lead on key populations. She has worked in the field of HIV for many years both at policy development, research and implementation. At WHO she developed the normative tools and guidelines on HIV and viral hepatitis for key populations. Annette continues to advocate for a public health response for key populations at global, regional and national level. An important part of these efforts are geared towards supporting countries to implement the recommended evidence based programmes and in setting national targets and monitoring progress along the cascade.|
|Abigael Lukhwaro||Abigael Lukhwaro program coordinator for Harm Reduction program at Medecins Du Monde Kenya program. I have 10 years experience in HIV programming 3 of which are in Harm Reduction for people who inject drugs . I have a Masters in Arts Degree and a Bachelors degree in Anthropology|
|Edo Agustian||Edo Agustian is the national coordinator of the Indonesian Drug Users' Network, also known by the acronym 'PKNI'. He led this organisation since 2011. PKNI consists of 26 self-organized group members across 19 provinces in Indonesia, and focuses on promoting the human rights of people who use drugs, advocating for evidence based drug policies, providing HIV services for people who use drugs, man who have sex with man and transgender in 12 provinces, and also involved actively in Hepatitis C testing, diagnose and treatment in collaboration with Ministry of Health. In 2014, PKNI got the International Red Ribbon Award for advocacy and human rights category in the AIDS Conference 2014 in Melbourne and Edo got the International Rolleston Award at the Harm Reduction Conference 2015 in Kuala Lumpur.|
|Annette Gaudino||Annette Gaudino has over 25 years of direct action organizing experience in the HIV, LGBT, and harm reduction movements. She joined TAG after four years with ACT UP New York, where she represented the group in the Safe Injecting Facility (SIF) NYC Coalition (now End Overdose NY), and connected ACT UP to hepatitis C advocates, leading to the formation of the NY State Hepatitis C Coalition. Annette previously served as Statewide Coordinator for Campaign for NY Health, where she worked with legislators and coalition partners to pass a single-payer health care bill in the State Assembly two years running.|
|Brian Conway||Dr. Brian Conway MD, FRCPC is a physician specializing in infectious diseases. He is the President and Medical Director of the Vancouver Infectious Diseases Centre, a non-profit medical research and care society dedicated to the development and evaluation of novel systems of treatment for HIV and HCV infections in vulnerable populations. Dr. Conway has conducted several clinical trials of HCV treatment among people who inject drugs (PWID) and leads a large cohort study generating “real world” data in this field.|
|Massimo Columbo||Professor Massimo Colombo is Director of the Center for Translational Research in Liver Disease at Humanitas Research Hospital ,Rozzano Italy.In the past 15 years he has been Chairman of the Division of Gastroenterology and Hepatology and Chairman of the Department of Medicine and Liver, Kidney, Lung, Bone Marrow and Organ Transplantation at IRCCS Maggiore Hospital in Milan, Italy. He has also been a Professor of Medicine and Gastroenterology at the University of Milan for more than 25 years. Professor Colombo gained his medical degree from the University of Milan, before completing a residency in gastroenterology at IRCCS Maggiore Hospital.
Research interests include the diagnosis and treatment of viral hepatitis and liver cancer. Recipient of numerous awards including the 2010 European Association Study Liver (EASL) Recognition Award for outstanding medical and scientific contributions, the Italian Association for the Study of the Liver (AISF) Distinguished Service Award, the Thanhauser Medal Award of the German Society of Gastroenterology and the Nelson Fausto Award of the International Liver Cancer Association(ILCA). Professor Colombo was Editor-in-Chief of the Journal of Hepatology from 2005–2009 and currently is AE of the Journal. In 2016 appointed Chairman of EASL International Liver Foundation,has authored more than 500 original manuscripts in peer-reviewed journals, with an H-index of 83.
|Alessio Aghemo||Prof. Aghemo received his medical degree from the University of Milan in 2001, where he also specialized in gastroenterology and later completed his post-doctoral research in gastroenterology. He served as the director of the hepatology outpatients clinic at the Gastroenterology and Hepatology Unit at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, until 2017. In 2017 he was appointed Associate Professor of Gastroenterology at the Humanitas University where he is the Head of The Internal Medicine and Hepatology Unit and The Center for the Study of Cirrhosis. He has contributed to the European and Italian clinical practice guidelines on the management and treatment of patients with chronic hepatitis C. From 2013 to 2016 he has served as a member of the governing board for the European Association for the Study of the Liver (EASL). He is currently involved in the United European Gastroenterology Scientific Committee as the official EASL-appointed member and serves as the Chair of the Italian Association for the Study of the Liver Commission on direct-acting antivirals for hepatitis C. Prof. Aghemo has published more than 160 peer-reviewed papers and is involved in many national and international clinical trials on the treatment of chronic hepatitis C.|
|Carla Treloar||Professor Carla Treloar is Director of the Centre for Social Research in Health and the Social Policy Research Centre at UNSW, Sydney. . Since 2001, she has conducted social research in HIV, viral hepatitis and sexually transmissible infections with a focus on the priority populations of people who use or inject drugs. She has been a member of more than 50 advisory committees for government, health agencies and non-government organisations and is committed to the effective translation of research into policy and practice and to ethical and respectful conduct of research in close collaboration with affected communities.|
|Francisco Inácio Bastos||Francisco Inácio Bastos is a Senior Researcher and former Chair of the Department of Epidemiology and Biostatistics at FIOCRUZ, with great experience on substance misuse research, particularly its association with HIV, viral hepatitis and other STIs/blood-borne infections (BBIs). He has been the PI on a number of large, multicity studies on HIV, BBIs & STIs. The data generated by these studies are the basis for current Brazilian policies and guidelines and for many studies in this area. Francisco recently coordinated the “National Household Survey on Alcohol and Substances Use and Misuse”, which has interviewed over 20,000 Brazilians all over the country.|
|Rick Lines||Rick Lines is Associate Professor of Criminology and Human Rights at the Hillary Rodham Clinton School of Law, Swansea University, Wales. He has been called ‘a key figure in the emerging field of human rights and drug policy’, and is known for his leading research and teaching on subjects including international drug control law, prisoners' rights, capital punishment and harm reduction. Rick is the author of ‘Drug Control and Human Rights in International Law’ (Cambridge University Press, 2017). From 2010 to 2018, he served as Executive Director of Harm Reduction International.|
|Alex Thompson||Alex Thompson is Professor-Director of Gastroenterology at St. Vincent’s Hospital Melbourne (University of Melbourne) Director of State-wide Hepatitis Program in Victorian prisons. His research interests include models of care for hepatitis with a focus on elimination and the identification of host and viral determinants of the natural history and treatment outcomes of hepatitis B and C viruses. Alex was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV. He has published widely in journals including Nature, Gastroenterology, Hepatology, Gut and Journal of Hepatology.|
|Joan Colom||• Director of the Programme on Substance Abuse. Department of Health. Government of Catalonia. Barcelona, Spain.
• Director of the Programme on Prevention, Control and Care for HIV, STDs and Viral Hepatitis.
• Advisor to the World Health Organization and is the Coordinator of the WHO Program Drink Less in Catalonia.
• Advisor to UN Drugs and collaborator with PAHO on training on EIBI programs.
• Master in Substances Abuse. University of Barcelona.
• Master in Executive Public Administration. ESADE. Barcelona.
• Degree in Medicine and Surgery. Medicine Faculty. Autonomous University of Barcelona
• Diploma in Public Health. National School of Health, Health School Carlos III (ISCIII) in collaboration with the School of Health Studies of Catalonia Barcelona (Spain).